-
2
-
-
0026531143
-
Histochemical mapping of nitric oxide synthase in the rat brain
-
Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992; 46: 755-784.
-
(1992)
Neuroscience
, vol.46
, pp. 755-784
-
-
Vincent, S.R.1
Kimura, H.2
-
3
-
-
0035313948
-
Nitric oxide: A novel link between synaptic and nonsynaptic transmission
-
Kiss JP, Vizi ES. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci 2001; 24: 211-215.
-
(2001)
Trends Neurosci
, vol.24
, pp. 211-215
-
-
Kiss, J.P.1
Vizi, E.S.2
-
4
-
-
45149088480
-
Concepts of neural nitric oxide-mediated transmission
-
Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 2008; 27: 2783-2802.
-
(2008)
Eur J Neurosci
, vol.27
, pp. 2783-2802
-
-
Garthwaite, J.1
-
5
-
-
20044387412
-
Role of nitric oxide on motor behavior
-
Del Bel EA, Guimaraes FS, Bermudez-Echeverry M, Gomes MZ, Schiaveto-de-souza A, Padovan-Neto FE, et al. Role of nitric oxide on motor behavior. Cell Mol Neurobiol 2005; 25: 371-392.
-
(2005)
Cell Mol Neurobiol
, vol.25
, pp. 371-392
-
-
del Bel, E.A.1
Guimaraes, F.S.2
Bermudez-Echeverry, M.3
Gomes, M.Z.4
Schiaveto-de-souza, A.5
Padovan-Neto, F.E.6
-
6
-
-
43049124353
-
Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons
-
Salum C, Raisman-Vozari R, Michel PP, Gomes MZ, Mitkovski M, Ferrario JE, et al. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons. Brain Res 2008; 1198: 27-33.
-
(2008)
Brain Res
, vol.1198
, pp. 27-33
-
-
Salum, C.1
Raisman-Vozari, R.2
Michel, P.P.3
Gomes, M.Z.4
Mitkovski, M.5
Ferrario, J.E.6
-
7
-
-
0037097153
-
Regulation of striatal dopamine neurotransmission by nitric oxide: Effector pathways and signaling mechanisms
-
West AR, Galloway MP, Grace AA. Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 2002; 44: 227-245.
-
(2002)
Synapse
, vol.44
, pp. 227-245
-
-
West, A.R.1
Galloway, M.P.2
Grace, A.A.3
-
8
-
-
0030847454
-
New and potent inhibitors of nitric oxide synthase reduce motor activity in mice
-
Dzoljic E, De Vries R, Dzoljic MR. New and potent inhibitors of nitric oxide synthase reduce motor activity in mice. Behav Brain Res 1997; 87: 209-212.
-
(1997)
Behav Brain Res
, vol.87
, pp. 209-212
-
-
Dzoljic, E.1
de Vries, R.2
Dzoljic, M.R.3
-
9
-
-
0028944688
-
Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats
-
Sandi C, Venero C, Guaza C. Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats. Eur J Pharmacol 1995; 277: 89-97.
-
(1995)
Eur J Pharmacol
, vol.277
, pp. 89-97
-
-
Sandi, C.1
Venero, C.2
Guaza, C.3
-
10
-
-
0029416823
-
L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice
-
Marras RA, Martins AP, Del Bel EA, Guimaraes FS. L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice. Neuroreport 1995; 7: 158-160.
-
(1995)
Neuroreport
, vol.7
, pp. 158-160
-
-
Marras, R.A.1
Martins, A.P.2
del Bel, E.A.3
Guimaraes, F.S.4
-
11
-
-
0033954727
-
Sub-chronic inhibition of nitricoxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice
-
Del Bel EA, Guimaraes FS. Sub-chronic inhibition of nitricoxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice. Psychopharmacology 2000; 147: 356-361.
-
(2000)
Psychopharmacology
, vol.147
, pp. 356-361
-
-
del Bel, E.A.1
Guimaraes, F.S.2
-
12
-
-
0037378689
-
Limitations of current Parkinson's disease therapy
-
Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL. Limitations of current Parkinson's disease therapy. Ann Neurol 2003; 53 (Suppl 3): S3-S12.
-
(2003)
Ann Neurol
, vol.53
, Issue.SUPPL. 3
-
-
Rascol, O.1
Payoux, P.2
Ory, F.3
Ferreira, J.J.4
Brefel-Courbon, C.5
Montastruc, J.L.6
-
13
-
-
50049087567
-
Molecular mechanisms of L-DOPA-induced dyskinesia
-
Jenner P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 2008; 9: 665-677.
-
(2008)
Nat Rev Neurosci
, vol.9
, pp. 665-677
-
-
Jenner, P.1
-
14
-
-
0344052684
-
Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
-
Grondin R, Bedard PJ, Hadj TA, Gregoire L, Mori A, Kase H. Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology 1999; 52: 1673-1677.
-
(1999)
Neurology
, vol.52
, pp. 1673-1677
-
-
Grondin, R.1
Bedard, P.J.2
Hadj, T.A.3
Gregoire, L.4
Mori, A.5
Kase, H.6
-
15
-
-
9144274541
-
Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates
-
Papa SM, Auberson YP, Greenamyre JT. Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates. Ann Neurol 2004; 56: 723-727.
-
(2004)
Ann Neurol
, vol.56
, pp. 723-727
-
-
Papa, S.M.1
Auberson, Y.P.2
Greenamyre, J.T.3
-
16
-
-
0029665122
-
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys
-
Papa SM, Chase TN. Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Ann Neurol 1996; 39: 574-578.
-
(1996)
Ann Neurol
, vol.39
, pp. 574-578
-
-
Papa, S.M.1
Chase, T.N.2
-
17
-
-
62349123821
-
Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
-
Padovan-Neto FE, Echeverry MB, Tumas V, Del-Bel EA. Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. Neuroscience 2009; 159: 927-935.
-
(2009)
Neuroscience
, vol.159
, pp. 927-935
-
-
Padovan-Neto, F.E.1
Echeverry, M.B.2
Tumas, V.3
Del-Bel, E.A.4
-
18
-
-
0031925945
-
L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA
-
Cenci MA, Lee CS, Bjorklund A. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 1998; 10: 2694-2706.
-
(1998)
Eur J Neurosci
, vol.10
, pp. 2694-2706
-
-
Cenci, M.A.1
Lee, C.S.2
Bjorklund, A.3
-
19
-
-
0036637271
-
Animal models of neurological deficits: How relevant is the rat?
-
Cenci MA, Whishaw IQ, Schallert T. Animal models of neurological deficits: how relevant is the rat? Nat Rev Neurosci 2002; 3: 574-579.
-
(2002)
Nat Rev Neurosci
, vol.3
, pp. 574-579
-
-
Cenci, M.A.1
Whishaw, I.Q.2
Schallert, T.3
-
20
-
-
0036459952
-
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
-
Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 2002; 15: 120-132.
-
(2002)
Eur J Neurosci
, vol.15
, pp. 120-132
-
-
Lundblad, M.1
Andersson, M.2
Winkler, C.3
Kirik, D.4
Wierup, N.5
Cenci, M.A.6
-
21
-
-
77953047191
-
Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery
-
Del-Bel EA, Guimaraes FS, Joca SR, Echeverry MB, Ferreira FR. Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery. J Psychopharmacol 2010; 24: 397-405.
-
(2010)
J Psychopharmacol
, vol.24
, pp. 397-405
-
-
Del-Bel, E.A.1
Guimaraes, F.S.2
Joca, S.R.3
Echeverry, M.B.4
Ferreira, F.R.5
-
22
-
-
58149359032
-
Priming for l-dopa-induced dyskinesia in Parkinson's disease: A feature inherent to the treatment or the disease?
-
Nadjar A, Gerfen CR, Bezard E. Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease? Prog Neurobiol 2009; 87: 1-9.
-
(2009)
Prog Neurobiol
, vol.87
, pp. 1-9
-
-
Nadjar, A.1
Gerfen, C.R.2
Bezard, E.3
-
23
-
-
0345293217
-
Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase
-
Gomes MZ, Del Bel EA. Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase. Brain Res Bull 2003; 62: 107-115.
-
(2003)
Brain Res Bull
, vol.62
, pp. 107-115
-
-
Gomes, M.Z.1
del Bel, E.A.2
-
25
-
-
0036070538
-
L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: Relation to motor and cellular parameters of nigrostriatal function
-
Winkler C, Kirik D, Bjorklund A, Cenci MA. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 2002; 10: 165-186.
-
(2002)
Neurobiol Dis
, vol.10
, pp. 165-186
-
-
Winkler, C.1
Kirik, D.2
Bjorklund, A.3
Cenci, M.A.4
-
26
-
-
0029064091
-
Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
-
Olsson M, Nikkhah G, Bentlage C, Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995; 15: 3863-3875.
-
(1995)
J Neurosci
, vol.15
, pp. 3863-3875
-
-
Olsson, M.1
Nikkhah, G.2
Bentlage, C.3
Bjorklund, A.4
-
27
-
-
0032889986
-
Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions
-
Chang JW, Wachtel SR, Young D, Kang UJ. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions. Neuroscience 1999; 88: 617-628.
-
(1999)
Neuroscience
, vol.88
, pp. 617-628
-
-
Chang, J.W.1
Wachtel, S.R.2
Young, D.3
Kang, U.J.4
-
28
-
-
40949097682
-
A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway
-
Gomes MZ, Raisman-Vozari R, Del Bel EA. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway. Brain Res 2008; 1203: 160-169.
-
(2008)
Brain Res
, vol.1203
, pp. 160-169
-
-
Gomes, M.Z.1
Raisman-Vozari, R.2
del Bel, E.A.3
-
29
-
-
40749157838
-
Advances in understanding LDOPA- induced dyskinesia
-
Cenci MA, Lindgren HS. Advances in understanding LDOPA- induced dyskinesia. Curr Opin Neurobiol 2007; 17: 665-671.
-
(2007)
Curr Opin Neurobiol
, vol.17
, pp. 665-671
-
-
Cenci, M.A.1
Lindgren, H.S.2
-
30
-
-
0024820634
-
Rationale for continuous dopaminomimetic therapy of Parkinson's disease
-
Chase TN, Baronti F, Fabbrini G, Heuser IJ, Juncos JL, Mouradian MM. Rationale for continuous dopaminomimetic therapy of Parkinson's disease. Neurology 1989; 39: 7-10.
-
(1989)
Neurology
, vol.39
, pp. 7-10
-
-
Chase, T.N.1
Baronti, F.2
Fabbrini, G.3
Heuser, I.J.4
Juncos, J.L.5
Mouradian, M.M.6
-
31
-
-
0035925693
-
Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum
-
Lopez A, Munoz A, Guerra MJ, Labandeira-Garcia JL. Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum. Neuroscience 2001; 103: 639-651.
-
(2001)
Neuroscience
, vol.103
, pp. 639-651
-
-
Lopez, A.1
Munoz, A.2
Guerra, M.J.3
Labandeira-Garcia, J.L.4
-
32
-
-
2942541214
-
Striatal plasticity and extrapyramidal motor dysfunction
-
Chase TN. Striatal plasticity and extrapyramidal motor dysfunction. Parkinsonism Relat Disord 2004; 10: 305-313.
-
(2004)
Parkinsonism Relat Disord
, vol.10
, pp. 305-313
-
-
Chase, T.N.1
-
33
-
-
34248201158
-
The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice
-
Chalimoniuk M, Langfort J. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochem Int 2007; 50: 821-833.
-
(2007)
Neurochem Int
, vol.50
, pp. 821-833
-
-
Chalimoniuk, M.1
Langfort, J.2
-
34
-
-
33745991786
-
Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
-
Chalimoniuk M, Lukacova N, Marsala J, Langfort J. Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Neuroscience 2006; 141: 1033-1046.
-
(2006)
Neuroscience
, vol.141
, pp. 1033-1046
-
-
Chalimoniuk, M.1
Lukacova, N.2
Marsala, J.3
Langfort, J.4
-
35
-
-
29344434297
-
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice
-
Pavon N, Martin AB, Mendialdua A, Moratalla R. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry 2006; 59: 64-74.
-
(2006)
Biol Psychiatry
, vol.59
, pp. 64-74
-
-
Pavon, N.1
Martin, A.B.2
Mendialdua, A.3
Moratalla, R.4
-
36
-
-
0029982104
-
Cerebrospinal fluid nitrate levels in patients with Parkinson's disease
-
Molina JA, Jimenez-Jimenez FJ, Navarro JA, Vargas C, Gomez P, Benito-Leon J, et al. Cerebrospinal fluid nitrate levels in patients with Parkinson's disease. Acta Neurol Scand 1996; 93: 123-126.
-
(1996)
Acta Neurol Scand
, vol.93
, pp. 123-126
-
-
Molina, J.A.1
Jimenez-Jimenez, F.J.2
Navarro, J.A.3
Vargas, C.4
Gomez, P.5
Benito-Leon, J.6
-
37
-
-
12344276324
-
Influence of the therapy with pergolide mesylate plus L-DOPA and with L-DOPA alone on serum cGMP level in PD patients
-
Chalimoniuk M, Stepien A. Influence of the therapy with pergolide mesylate plus L-DOPA and with L-DOPA alone on serum cGMP level in PD patients. Pol J Pharmacol 2004; 56: 647-650.
-
(2004)
Pol J Pharmacol
, vol.56
, pp. 647-650
-
-
Chalimoniuk, M.1
Stepien, A.2
-
38
-
-
0032835969
-
Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment
-
Cenci MA, Tranberg A, Andersson M, Hilbertson A. Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment. Neuroscience 1999; 94: 515-527.
-
(1999)
Neuroscience
, vol.94
, pp. 515-527
-
-
Cenci, M.A.1
Tranberg, A.2
Andersson, M.3
Hilbertson, A.4
-
39
-
-
33244477604
-
Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism
-
Sammut S, Dec A, Mitchell D, Linardakis J, Ortiguela M, West AR. Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism. Neuro-0psychopharmacology 2006; 31: 493-505.
-
(2006)
Neuro-0psychopharmacology
, vol.31
, pp. 493-505
-
-
Sammut, S.1
Dec, A.2
Mitchell, D.3
Linardakis, J.4
Ortiguela, M.5
West, A.R.6
-
40
-
-
1442300196
-
The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity states and electrophysiological properties of striatal medium spiny neurons recorded in vivo
-
West AR, Grace AA. The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity states and electrophysiological properties of striatal medium spiny neurons recorded in vivo. J Neurosci 2004; 24: 1924-1935.
-
(2004)
J Neurosci
, vol.24
, pp. 1924-1935
-
-
West, A.R.1
Grace, A.A.2
|